HomeNewsTrendsCoronavirus pandemic | In a first, COVID-19 recoveries in India overtake active cases

Coronavirus pandemic | In a first, COVID-19 recoveries in India overtake active cases

The overall novel coronavirus recovery rate in India has increased to 48.9 percent, even as the total COVID-19 death toll is nearing 7,500

June 10, 2020 / 14:35 IST
Story continues below Advertisement

At a time when India’s coronavirus tally is increasing by almost 10,000 cases daily, the Union Health Ministry informed that for the first time, the number of COVID-19 recoveries surpassed the number of active cases in the country.

As per the latest figures released by the Ministry of Health and Family Welfare, the number of patients who have recovered from COVID-19 since the outbreak of the coronavirus pandemic in India stands at 1,35,205 right now. Against this, the number of active coronavirus cases in India as of June 10 stands at 1,33,632.

Story continues below Advertisement

For live updates on coronavirus, click here

India’s total coronavirus count is around 2.77 lakh at present, with the death toll nearing 7,500. Meanwhile, the overall novel coronavirus recovery rate in India has increased to 48.9 percent.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show